The FDA Peptide Crackdown: Regulatory Capture, Not Patient Safety
BPC-157, GHK-Cu, MOTS-c, and a dozen other peptides have been pushed off the legal compounding market. The justification is safety. The reality is regulatory capture. Here is the honest read.